Phase 2 Extranodal Marginal Zone Lymphoma Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma
Extranodal Marginal Zone Lymphoma
Izidore Lossos, MD35 enrolled1 locationNCT06569680
Recruiting
Phase 2
Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)
Marginal Zone LymphomaSplenic Marginal Zone LymphomaExtranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue+1 more
Izidore Lossos, MD25 enrolled1 locationNCT06796998